Strobel, D.
Jung, E.-M.
Ziesch, M.
Praktiknjo, M.
Link, A.
Dietrich, C. F.
Klinger, C.
Schultheiß, M.
Jesper, D.
Schellhaas, B. http://orcid.org/0000-0002-5499-6080
Funding for this research was provided by:
Deutsche Gesellschaft für Ultraschall in der Medizin
Article History
Received: 31 December 2020
Revised: 17 February 2021
Accepted: 11 March 2021
First Online: 15 April 2021
Declarations
:
: The scientific guarantor of this publication is Prof. Dr. Deike Strobel, Department of Medicine 1, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: Dr. Christine Gall, Institute for Biometrics, Epidemiology and Statistics (IMBE), FAU Erlangen Nürnberg, kindly provided statistical advice for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in Schellhaas B et al, Ultraschall Med. 2020 Jul 27. doi: 10.1055/a-1220-8561. This study is a prospective multicenter study. However, the former study focused on the subcollective of high-risk patients (including risk factors other than cirrhosis) with histological findings available only, whereas the current manuscript deals with the subcollective of cirrhotic patients only and includes MRI or CT as the reference standard in patients with no histological findings available.
: • prospective• diagnostic or prognostic study• multicenter study